Type 1A diabetes induced by infection and immunization

Journal of Autoimmunity
D T Robles, George S Eisenbarth

Abstract

Type 1A diabetes is an immune mediated disorder that results from progressive destruction of the islet beta-cells in the setting of genetic susceptibility. Both MHC and non-MHC genes contribute to disease with class II HLA molecules major determinants of susceptibility or protection. The presence of multiple anti-islet autoantibodies is associated with a high risk of disease progression, and the first anti-islet autoantibodies may appear as early as the first year of life. Congenital rubella is the only infection clearly associated with the development of type 1A diabetes. With the ability to detect children in the first year of life activating autoimmunity, prospective studies may in the future document additional environmental factors either increasing or decreasing diabetes risk.

References

May 1, 1992·Epidemiology·J N KostrabaR F Hamman
Nov 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·Z J ZhangH L Weiner
Nov 1, 1986·The American Journal of Medicine·S L RabinoweG S Eisenbarth
Mar 1, 1984·The Journal of Pediatrics·W L ClarkeW E Nance
May 1, 1983·The Journal of Pediatrics·F KurtzG R Hauptmann
Dec 1, 1982·Diabetes·P RubinsteinF Ginsberg-Fellner
Jan 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·D Daniel, D R Wegmann
Jul 1, 1996·Diabetes/metabolism Reviews·J P MordesA A Rossini
Feb 1, 1997·Transplantation Proceedings·M CrawfordR G Gill
Sep 23, 1997·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·A I RamsinghS Tracy
Feb 5, 1999·Human Molecular Genetics·P BjörsesI Ulmanen
Apr 20, 1999·Biochemical and Biophysical Research Communications·M HeinoK Krohn
Oct 26, 1999·BMJ : British Medical Journal·J B Classen, D C Classen

❮ Previous
Next ❯

Citations

Feb 1, 2006·Pediatric Dermatology·Marimar Saez-De-OcarizRamon Ruiz-Maldonado
Feb 28, 2006·Journal of Virology·J Denise WetzelTerence S Dermody
Oct 6, 2009·Medical Hypotheses·Daniel J Moore
Jul 21, 2009·Biochemical and Biophysical Research Communications·Dariush MokhtariMichael Welsh
Apr 8, 2009·Journal of Autoimmunity·Anura Hewagama, Bruce Richardson
Jan 6, 2009·Annals of the New York Academy of Sciences·Rita BortellAldo A Rossini
Mar 15, 2006·Lancet·Denis Daneman
Jul 3, 2002·Endocrinology and Metabolism Clinics of North America·Edwin Liu, George S Eisenbarth
Oct 27, 2005·Diabetes·Katja RadonUNKNOWN Chronic Autoimmune Disease and Contact to Animals (CAT) Study Group
Oct 6, 2010·Journal of Diabetes Science and Technology·Marco Songini, Cira Lombardo
Mar 29, 2002·Nature Immunology·Malin FlodströmNora Sarvetnick
Mar 29, 2019·Clinical Oral Implants Research·Aneesha AcharyaNikos Mattheos
Dec 6, 2003·Pediatric Diabetes·Joel N Hirschhorn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.